8. ハンチントン病 Huntington disease Clinical trials / Disease details
臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01485952 (ClinicalTrials.gov) | March 2011 | 29/11/2011 | An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196 | An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients to Assess Pharmacokinetics, Candidate Pharmacodynamic Measures of Target Engagement and Disease Modulation as Well as Acute Phenotypical Effects Following Multiple Oral Doses of SEN0014196. | Huntington Disease | Drug: SEN0014196 (Low Dose);Drug: SEN0014196 (High Dose);Drug: Placebo | Siena Biotech S.p.A. | Seventh Framework Programme;European Huntington's Disease Network | Completed | 18 Years | 70 Years | Both | 55 | Phase 1 | Germany |